Anxiety and depressive disorders in Parkinson's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
G N AkhmadeevaI M Hidijatova

Abstract

This review presents the most recent data of worldwide research on anxiety and depressive disorders in patients with Parkinson's disease. Their characteristics and epidemiology, pathogenetic and clinical features, methods of diagnosis and treatment are presented. Depression occurs in 40-50% of patients with PD, anxiety in 17-43% of patients. Pramipexole, a dopamine agonist, is only one drug recommended for depression treatment. Nortriptyline and desipramine, belonging to the group of tricyclic antidepressants (TCAs), are considered to be possibly effective. There are no clear recommendations for treatment of anxiety. In general, methods of therapy of anxiety and depressive disorders in PD are not well understood which determines the conduct of large-scale studies in the future.

References

Jan 1, 1990·Journal of Geriatric Psychiatry and Neurology·T S EhmannR J Riopelle
Jan 1, 1990·The Journal of Nervous and Mental Disease·S E StarksteinR G Robinson
Oct 1, 1993·Biological Psychiatry·M A MenzaA S Bonapace
Jan 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·S A ColeR L Watts
Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·S E StarksteinR Leiguarda
Jun 1, 2002·Parkinsonism & Related Disorders·L M ShulmanW J Weiner
Oct 16, 2002·Neuropsychobiology·Svenja HappeUNKNOWN FAQT study investigators
Jan 31, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·A F G LeentjensF R J Verhey
Sep 12, 2003·Journal of Geriatric Psychiatry and Neurology·Daniel WeintraubMatthew B Stern
Sep 23, 2003·Parkinsonism & Related Disorders·A RojoS Quintana
Aug 18, 2004·Journal of Geriatric Psychiatry and Neurology·Albert F G Leentjens
Dec 23, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I RektorováJ Velísková
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Laura MarshUNKNOWN NINDS/NIMH Work Group on Depression and Parkinson's Disease
Dec 22, 2005·Acta Neurologica Scandinavica·A Lieberman
Jul 13, 2006·Neurology·L Kirsch-DarrowD Bowers
Mar 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragChristopher G Goetz
Nov 8, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Jennifer S A M ReijndersAlbert F G Leentjens
Dec 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sergio E StarksteinRobert G Robinson
Mar 4, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·David DevosLuc Defebvre
Jul 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Sarra NazemDaniel Weintraub
Jul 29, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Arthur KummerAntonio L Teixeira
Sep 1, 2006·Neuropsychiatric Disease and Treatment·Irene Hegeman Richard, Roger Kurlan
May 19, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·A AlonsoM A Hernán
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneUNKNOWN PRIAMO study group
Dec 18, 2009·Journal of Geriatric Psychiatry and Neurology·Miyako OguruNobuyuki Oka
May 13, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Nadeeka N W DissanayakaGeorge D Mellick
Oct 20, 2010·Journal of Neurology·Juan Carlos Gómez-EstebanJuan J Zarranz
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Albert F G LeentjensSergio E Starkstein
Nov 2, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Klaus SeppiCristina Sampaio
Apr 10, 2013·Neuropsychiatric Disease and Treatment·Francesca AssognaGianfranco Spalletta
Jun 26, 2013·Pharmacotherapy·Jack J Chen, Laura Marsh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.